ReachMD

We now have many choices of oral agents in the treatment of type 2 diabetes patients. But choosing the type and where they fit in the treatment algorithm can be a challenge. Join host Dr. Steven Edelman and his guest, director of the Harold Schnitzer Diabetes Health Center, Dr. Andrew Ahmann, as they discuss the different classes of oral agents, benefits and treatment algorithms in the treatment of type 2 diabetes.